Cisplatin binding

Author: ktks

August undefined, 2024

WebJun 20, 2024 · We propose here a new mechanism of cisplatin resistance mediated by glutathione transferase (GST) P1-1, as a cisplatin-binding protein. Our results show … WebMay 26, 2024 · Using the fluorescent cisplatin analog BODIPY-cisplatin, two-dimensional gel electrophoresis, and mass spectrometry, we identified the protein binding partners in …

Kinetics of cisplatin binding to cellular DNA and modulations by …

WebKinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs. DNA platination by cisplatin (CDDP) was investigated in peripheral blood … WebMar 25, 2024 · Given that apoptosis resistance is one of the causes of the cisplatin resistance of tumor cells, our aim was to determine the relationship between RRS1 and cisplatin resistance in breast cancer cells. Here, we report that RRS1 is associated with cisplatin resistance in breast cancer cells. css builders

Cisplatin binding to human serum albumin: a structural …

WebJul 24, 2024 · The aim of this work is to identify the cisplatin binding sites on human H-chain ferritin. High-resolution X-ray crystallography reveals that cisplatin binds four distinct protein sites, that is, the side chains of His136 and Lys68, the side chain of His105, the side chain of Cys90 and the side chain of Cys102. WebMar 29, 2024 · Cisplatin binds to the copper-binding sites in the N-terminal domain of ATP7B; this binding may be an essential step of cisplatin detoxification involving copper ATPases. COX19 is necessary for the transduction of a SCO1-dependent mitochondrial redox signal that regulates ATP7A-mediated cellular copper efflux. WebJun 15, 2024 · Wang et al. indicated that miR-17 targets c-Jun activation domain binding protein 1 (JAB1) to promote tumor growth and cisplatin (DDP) resistance of TNBC . As far as we know, chemotherapy is the standard therapeutic strategy for TNBC, and DDP is the most widely used chemotherapeutic drug for solid tumors. ear crystal physical therapy

Cisplatin Binding to Human Serum Transferrin: A Crystallographic …

Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human …

WebThe binding affinity of ligands in this study was evaluated on the basis of E-value (kcal/mol), number of hydrogen bonds, pi-pi bonds and other hydrophobic interactions against selected targets that are reported to be involved in development of resistance of cancer cells against cisplatin (Figure 6; Table 3). WebCisplatin binds to two adjacent guanines, called crosslinking, at the N7 position. [1] Cisplatin’s ability to bind to adjacent guanines arises from its cis structure, as the cis chlorines can be exchanged for water molecules … cssbuilds.comWebApr 6, 2024 · Cisplatin (Platinol) is an inorganic coordination complex with a broad range of antitumor activity. It is especially useful in the treatment of testicular and ovarian cancer. It binds to DNA at nucleophilic sites, such as the N7 and O6 of guanine, producing alterations in DNA structure and inhibition of DNA synthesis. css bugs

"WebCisplatin is a platinum-based chemotherapeutic that has long since been effective against a variety of solid-cancers, substantially improving the five-year survival rates for cancer patients. Its use has also historically been limited by its adverse drug reactions, or cisplatin-induced toxicities (CITs). Of these reactions, cisplatin-induced nephrotoxicity (CIN), … " - Cisplatin binding

Cisplatin binding

WebSep 1, 2024 · Cisplatin dose not undergo the instantaneously and reversible binding to plasma protein that is characteristic of normal drug-protein binding. Platinum from … WebThe current accepted paradigm about cisplatin mechanism of action is that the drug induces its cytotoxic properties through binding to nuclear DNA and subsequent interference with normal transcription, and/or DNA replication mechanisms.

Did you know?

WebJun 6, 2014 · DNA Binding DNA is the typical cellular target of cisplatin, and so the ability of 4 to platinate nuclear DNA was assessed. Five million A2780 cells were treated with growth medium containing 5 μM cisplatin, 4a, or 4e for 5 h, followed by incubation in fresh media for an additional 16 h. WebThe binding of cisplatin has been modelled by using molecular dynamic simulations and the results suggest that cisplatin can occupy part of both the iron(III)- and carbonate-binding sites in the C-terminal lobe of the protein.

WebJan 5, 2024 · Cisplatin, cis -diammineplatinum (II) dichloride, is a DNA-damaging anticancer agent widely used for the treatment of many forms of solid tumors. (1−6) It … WebThe combination of adenoviruses and chemotherapy agents is a novel approach for human cancer therapeutics. A meticulous analysis between adenovirus and chemotherapeutic agents can help to design an effective anticancer therapy. Human antigen R (HuR) is an RNA binding protein that binds to the AU-rich element (ARE) of specific mRNA and is …

WebApr 10, 2024 · Triple-negative breast cancer (TNBC) is one of the most aggressive forms of breast cancer and constitutes 10–20% of all breast cancer cases. Even though platinum-based drugs such as cisplatin and carboplatin are effective in TNBC patients, their toxicity and development of cancer drug resistance often hamper their clinical use. Hence, novel … WebAug 19, 2005 · Binding of cisplatin to proteins reduces urinary excretion of platinum, and causes deposition of platinum in tissues. Binding of cisplatin to proteins and enzymes is generally believed to be the cause of several severe side effects exhibited by these drugs, especially ototoxicity and nephrotoxicity.

WebMay 15, 2016 · The cisplatin fragments can coordinate protein side chains either in a monodentate fashion (as in the case of the binding sites observed in HSA-cisplatin, …

WebAug 2, 2016 · Our data reveal unexpected cisplatin binding sites on the protein surface that could have general significance: cisplatin fragments − [Pt (NH 3) 2 Cl] +, − [Pt (NH 3 )Cl 2 ], and − [Pt (NH 3) 2 (OH 2 )] 2+ bind … ear crystal manipulationWebOct 21, 2016 · Where Does Cisplatin Bind? Genome-wide Assay System Detects Cisplatin Action Sites Cisplatin is one of the most widely used agents in cancer chemotherapy. Its … ear crystal fixWebJul 24, 2024 · The aim of this work is to identify the cisplatin binding sites on human H-chain ferritin. High-resolution X-ray crystallography reveals that cisplatin binds four … ear crystal issuesWebCisplatin (DDP) is a common therapeutic option for non-small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. Therefore, identifying novel biomarkers to improve the diagnosis and treatment of NSCLC is important. css build mobileWebCisplatin is administered through a vein (intravenously or IV) as an infusion. There is no pill form of cisplatin. Cisplatin is an irritant. An irritant is a chemical that can cause inflammation of the vein through which it is given. If cisplatin escapes from the vein it can cause tissue damage. ear cropsWebAug 10, 2024 · Binding of cis -DDP to DNA inhibits replication both in vivo and in vitro, as shown by a variety of assays. Inhibition of replication of SV40 viral DNA in African green monkey cells as a function of the concentration of added cis -DDP is shown in Figure 9.17. css building iiiWebNov 15, 1987 · Two sublines were derived from a human bladder carcinoma continuous cell line (RT112-P), one by exposure to fractionated X-irradiation (RT112-DXR8) and the other by continuous exposure to cisplatin (RT112-CP). RT112-DXR8 cells were 1.6- to 2-fold more sensitive to cisplatin and 2 analogues, carbopla … css building